Louis reserves judgment on Cavadex until a human trial is published
Louis shares a Dr. Ford Brewer video giving a negative review of Cavadex, a cyclodextrin product marketed for heart disease. He says he knows little and will wait for a human trial.
3 posts
Louis shares a Dr. Ford Brewer video giving a negative review of Cavadex, a cyclodextrin product marketed for heart disease. He says he knows little and will wait for a human trial.
Louis notes a case series of 20 patients taking cyclodextrin was recently published, cautioning that case series sit at the bottom of the evidence hierarchy but that research has to start somewhere.

Louis notes that cyclodextrin, a controversial alternative heart disease treatment, may help treat Alzheimer's, with a news item on an MIT patent deal targeting brain cholesterol transport in ApoE4-linked disease.